Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
- PMID: 34657152
- PMCID: PMC9402694
- DOI: 10.1093/cid/ciab909
Severity, Criticality, and Fatality of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Beta Variant
Abstract
Beta (B.1.351)-variant coronavirus disease 2019 (COVID-19) disease was investigated in Qatar. Compared with the Alpha (B.1.1.7) variant, odds (95% confidence interval) of progressing to severe disease, critical disease, and COVID-19-related death were 1.24-fold (1.11-1.39), 1.49-fold (1.13-1.97), and 1.57-fold (1.03-2.43) higher, respectively, for the Beta variant.
Keywords: SARS-CoV-2; epidemiology; infection; severe disease; variant.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
References
-
- World Health Organization. Tracking SARS-CoV-2 variants. 2021. Available at: https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/. Accessed 5 June 2021.
-
- Chemaitelly H, Yassine HM, Benslimane FM, et al. . mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar. Nat Med 2021; 27:1614–21. - PubMed
-
- National Project of Surveillance for Variants of Concern and Viral Genome Sequencing. Qatar viral genome sequencing data. Data on randomly collected samples. Available at: https://www.gisaid.org/phylodynamics/global/nextstrain/. Accessed 11 October 2021.
-
- Benslimane FM, Al Khatib HA, Al-Jamal O, et al. . One year of SARS-CoV-2: genomic characterization of COVID-19 outbreak in Qatar. medRxiv [Preprint]. May 20, 2021. Available at: https://www.medrxiv.org/content/10.1101/2021.05.19.21257433v2. Accessed 11 October 2021. - DOI - PMC - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous